17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients

Mazzaschi, G. ; Milanese, G. ; Moron Dalla Tor, L. ; Leo, L. ; Balbi, M. ; Trentini, F. ; Manini, M. ; Pavone, C. ; Silva, M. ; Ledda, R.E. ; Minari, R. ; Bordi, P. ; Buti, S. ; Leonetti, A. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.

Texto completo disponível

1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC

Mazzaschi, G. ; Moron Dalla Tor, L. ; Balbi, M. ; Milanese, G. ; Tognazzi, D. ; Lorusso, B. ; Trentini, F. ; Di Rienzo, G. ; Verzè, M. ; Pluchino, M. ; Minari, R. ; Leo, L. ; Gnetti, L. ; Bordi, P. ; Leonetti, A. ; Ampollini, L. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.

Texto completo disponível

Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

del Carpio, L.P. ; Gomila, P. ; Camacho, S.D. ; Moron, S. ; Riudavets, M. ; Molto, C. ; Bujosa, A. ; Borrell, M. ; Teres, R. ; Martin, B. ; Gallardo, P. ; Acosta, E. ; Tilea, L. ; Soto, A. ; De Quintana, C. ; Craven-Bartle, J. ; Gallardo, A. ; Gomez, B. ; Bonilla, S. ; Gallego, O.

England: Elsevier Ltd

Texto completo disponível

Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

Riudavets Melia, M. ; Gabriela Sullivan, I. ; Barba Joaquín, A. ; Anguera Palacios, G. ; del Carpio, L.P. ; Molto Valiente, C. ; Camacho Arellano, S.D. ; Moron Asensio, S. ; Gomila Pons, P. ; Andres Granyó, M. ; Castillo Villegas, D. ; Facundo Molas, C. ; Garcia Planella, E. ; González Blanco, C. ; Barnadas Molins, A. ; Gich Saladich, I. ; Majem Tarruella, M.

England: Elsevier Ltd

Texto completo disponível

Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V. ; Gil-Martin, M. ; Johnson, M. ; Aljumaily, R. ; Lopez Criado, P. ; Northfelt, D.W. ; Crittenden, M. ; Jabbour, S. ; Rosen, L. ; Garrido Lopez, P. ; Hervás Morón, A. ; Rietschel, P. ; Mohan, K.K. ; Li, J. ; Stankevich, E. ; Rowlands, T. ; Feng, M. ; Lowy, I. ; Fury, M.G.

England: Elsevier Ltd

Texto completo disponível

1589P Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

Gonzalez Caraballo, I. ; Martín Lozano, R. ; Jiménez Rodríguez, R. ; Lobato Delgado, B. ; Cañete Muñoz, M.A. ; Benavente, M. ; Palma, M. ; De Toro Carmena, M.T. ; Morón, B.I. ; Tirado Anula, V.C. ; Soto Alsar, J. ; Bringas Beranek, M. ; Gutierrez Alonso, N. ; López Jiménez, C. ; Gutiérrez Ortiz de la Tabla, A. ; Juliao Caamaño, D.S. ; Ortega Morán, L. ; Soria Fernandez, J.M. ; Martin Jimenez, M. ; Munoz Martin, A.J.

Texto completo disponível

P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation

Ortega Morán, L. ; Pesántez, D. ; Brozos Vázquez, E. ; Fernández Garay, D. ; Lobo de Mena, M. ; Ribera Fernández, P. ; Sánchez Cánovas, M. ; Salgado Fernandez, M. ; García Pérez, E. ; Iriarte Moncho, E. ; Morón García, B. ; Font, C. ; Gallardo, E. ; Pérez Altozano, J. ; Muñoz Martín, A.

Texto completo disponível

388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

del Carpio, L P ; Gomila, P ; Camacho, S D ; Moron, S ; Riudavets, M ; Molto, C ; Bujosa, A ; Borrell, M ; Teres, R ; Martin, B ; Gallardo, P ; Acosta, E ; Tilea, L ; Soto, A ; De Quintana, C ; Craven-Bartle, J ; Gallardo, A ; Gomez, B ; Bonilla, S ; Gallego, O

Oxford University Press

Texto completo disponível

Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V. ; Gil-Martin, M. ; Johnson, M.L. ; Aljumaily, R. ; Lopez Criado, P. ; Northfelt, D.W. ; Crittenden, M. ; Jabbour, S. ; Rosen, L. ; Garrido, P. ; Hervás Morón, A. ; Rietschel, P. ; Mohan, K.K. ; Li, J. ; Stankevich, E. ; Feng, M. ; Lowy, I. ; Fury, M.G.

Elsevier Ltd

Texto completo disponível

1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

Riudavets Melia, M ; Gabriela Sullivan, I ; Barba Joaquín, A ; Anguera Palacios, G ; del Carpio, L P ; Molto Valiente, C ; Camacho Arellano, S D ; Moron Asensio, S ; Gomila Pons, P ; Andres Granyó, M ; Castillo Villegas, D ; Facundo Molas, C ; Garcia Planella, E ; González Blanco, C ; Barnadas Molins, A ; Gich Saladich, I ; Majem Tarruella, M

Oxford University Press

Texto completo disponível